CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- 4/A Open-market buy Director bought 1,240 shares at $24.15 ($29,943)
- CORRESP Other Correspondence Between Filers and SEC Staff
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy Director bought 1,240 shares at $24.15 ($29,943)
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement · New debt or obligation · Other events
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market sale President & CEO sold 194,490 shares at an average $42.75 ($8,313,601)
- 4 Open-market sale Chief Operating Officer sold 54,215 shares at an average $42.75 ($2,317,599)
- 4 Open-market sale Chief Financial Officer sold 50,309 shares at an average $42.75 ($2,150,595)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 144 Insider Sale of Securities
Page 5 of 33 · 652 filings